232 related articles for article (PubMed ID: 15654129)
21. PPARα/HNF4α interplay on diversified responsive elements. Relevance in the regulation of liver peroxisomal fatty acid catabolism.
Chamouton J; Latruffe N
Curr Drug Metab; 2012 Dec; 13(10):1436-53. PubMed ID: 22978398
[TBL] [Abstract][Full Text] [Related]
22. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
23. Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice.
Ellinghaus P; Wolfrum C; Assmann G; Spener F; Seedorf U
J Biol Chem; 1999 Jan; 274(5):2766-72. PubMed ID: 9915808
[TBL] [Abstract][Full Text] [Related]
24. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα.
Tahri-Joutey M; Andreoletti P; Surapureddi S; Nasser B; Cherkaoui-Malki M; Latruffe N
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445672
[TBL] [Abstract][Full Text] [Related]
26. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
27. Phytol directly activates peroxisome proliferator-activated receptor alpha (PPARalpha) and regulates gene expression involved in lipid metabolism in PPARalpha-expressing HepG2 hepatocytes.
Goto T; Takahashi N; Kato S; Egawa K; Ebisu S; Moriyama T; Fushiki T; Kawada T
Biochem Biophys Res Commun; 2005 Nov; 337(2):440-5. PubMed ID: 16202384
[TBL] [Abstract][Full Text] [Related]
28. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
29. Influence of virgin coconut oil-enriched diet on the transcriptional regulation of fatty acid synthesis and oxidation in rats - a comparative study.
Arunima S; Rajamohan T
Br J Nutr; 2014 May; 111(10):1782-90. PubMed ID: 24513138
[TBL] [Abstract][Full Text] [Related]
30. Sexually dimorphic metabolism of branched-chain lipids in C57BL/6J mice.
Atshaves BP; Payne HR; McIntosh AL; Tichy SE; Russell D; Kier AB; Schroeder F
J Lipid Res; 2004 May; 45(5):812-30. PubMed ID: 14993239
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.
Kersten S; Seydoux J; Peters JM; Gonzalez FJ; Desvergne B; Wahli W
J Clin Invest; 1999 Jun; 103(11):1489-98. PubMed ID: 10359558
[TBL] [Abstract][Full Text] [Related]
32. The metabolism of phytanic acid and pristanic acid in man: a review.
Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
[TBL] [Abstract][Full Text] [Related]
33. PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
Xu Y; Denning KL; Lu Y
Biochem Biophys Res Commun; 2022 Jul; 613():47-52. PubMed ID: 35526488
[TBL] [Abstract][Full Text] [Related]
34. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
[TBL] [Abstract][Full Text] [Related]
35.
Van Veldhoven PP; de Schryver E; Young SG; Zwijsen A; Fransen M; Espeel M; Baes M; Van Ael E
Front Cell Dev Biol; 2020; 8():144. PubMed ID: 32266253
[TBL] [Abstract][Full Text] [Related]
36. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells.
Hsu MH; Savas U; Griffin KJ; Johnson EF
J Biol Chem; 2001 Jul; 276(30):27950-8. PubMed ID: 11371553
[TBL] [Abstract][Full Text] [Related]
37. Phytanic acid metabolism in health and disease.
Wanders RJ; Komen J; Ferdinandusse S
Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
[TBL] [Abstract][Full Text] [Related]
38. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
39. Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein.
Wolfrum C; Ellinghaus P; Fobker M; Seedorf U; Assmann G; Börchers T; Spener F
J Lipid Res; 1999 Apr; 40(4):708-14. PubMed ID: 10191295
[TBL] [Abstract][Full Text] [Related]
40. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
